On the additive artificial intelligence-based discovery of nanoparticle neurodegenerative disease drug delivery systems

HIGHLIGHTS

• What: The authors utilized the IFPTML model to investigate N2D3Ss, encompassing assays of ADs and preclinical assays for NPs. The aim of this function is to increase the effect of certainty and maintain the homogeneity of scales. The IFPTML-LNN models in this work showed lower Sn and Sp values of 64%-65% in the training and validation series, compared with the IFPTML-LDA models, see details in Table 2. If the authors compare the linear IFPTML-ANN model with non-linear models based on the results of statistical parameters, the authors can confirm that N2D3S is . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.